United States of Cannabis
A funny thing is happening in the halls of Congress this summer…
Mortal political enemies are suddenly finding themselves on the same side of a divisive issue.
In an interview with Rolling Stone, Sen. Elizabeth Warren said making cannabis regulation a state issue would come to a vote if Democrats take the Senate in November.
“… and the vote will carry,” she told the magazine.
Warren is a polarizing figure in Washington. Liberals love her. Conservatives hate her.
Which is why it’s so interesting that so many Republicans are siding with her on a controversial issue like cannabis legalization. The numbers are growing too.
A handful of Republican lawmakers are supportive of pot legalization today.
Conservative Dana Rohrabacher was a driving force for legalization in his home state of California, and he himself has used cannabidiols to cope with pain following a shoulder replacement.
The Flip-Side of Things
Then there’s John Boehner, former Republican speaker of the House, who infamously said he was “unalterably opposed” to cannabis. This is until he joined the board of a legal cannabis company earlier this year.
Guys like Boehner are arguably better advocates for legalizing pot at a federal level because of the hard-line views they held in the past.
Legalizing pot even made the 2018 platform of the Texas state Republican Party.
These aren’t small shifts.
But they’re not totally surprising, either.
After all, states’ rights have historically been a key conservative rallying cry, not a liberal one.
The libertarian wave has taken a significant role in national conservative politics over the last four years. This movement is built on keeping the government’s nose out of Americans’ business — and that extends to cannabis.
Weird as it seems, that means that a swath of Republicans could soon be aligned with super-Democrats like Elizabeth Warren on cannabis legalization.
The net result is the fact that we’ll almost certainly see the United States Congress provide a path to full federal legalization throughout the U.S. soon.
That move will unlock massive profit opportunities for you as American marijuana companies suddenly become able to cross state and international borders.
And that’s just the beginning.
Meanwhile, here’s a look at how some of our recent Technology Profits Daily watch list pot plays are faring.
How Tech Profits Daily Makes YOU Money
Cronos Group Inc. (NASDAQ: CRON), first added to our watch list on March 6, at $10.22, sat at $12.45 yesterday. Up 21.82%.
GW Pharmaceuticals (NASDAQ: GWPH), first introduced to followers on April 9 at $112.05 per share closed yesterday at $144.82. Now up over 29% to date.
MariMed Inc. (OTCBB: MRMD) is breaking out as we speak, up over 82% since adding it to our watch list at a price of $1.55 on May 30. Yesterday the stock closed at $2.83.
Tilray Inc. (NASDAQ: TLRY), first introduced on July 20 at its post-IPO price of $24.25, is up an amazing 243%.
Tilray could run higher, but at $89.86 as of yesterday’s close, this play’s a lot riskier today than a week ago. Never chase price.
Most importantly, this is only a small sample of how my research can work for you and your money.
To a bright future.
For Technology Profits Daily,
Chief Technology Expert, Technology Profits Daily
Editor’s note: Remember, these are watch list plays, not Ray’s official recommendations. We will not be tracking these, and if you decide to act, please do your own research as well. Never bet more money than you can afford to lose.